People · Operator
Named in public records as an officer, director or promoter · active 2014–2014 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NinePoint Medical, Inc. | — | Other Health Care | Series B | $70.4M | $679.4M | 2014 |
Mark M. Stautberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mark M. Stautberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Russell Hirsch | 1 | 10 |
| Mark Levin | 1 | 9 |
| Mitchell Bloom | 1 | 6 |
| Charles Carignan | 1 | 3 |
| Kevin Gillis | 1 | 3 |
| Eric Swanson | 1 | 3 |
| Judith M. Huber | 1 | 2 |
| Thomas J. Miller | 1 | 2 |
| Curt M. Weinstein | 1 | 1 |
| Christopher Von Jako | 1 | 1 |
| Mark J. Stautberg | 1 | 1 |
| Curt J. Weinstein | 1 | 1 |
| Scott J. Gazelle | 1 | 1 |
| Henry J. Lee | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.